Pinned post
We have a new op-ed out today in @washingtonpost examining the high costs of treating asthma and COPD in the US.
Unless Congress and the FDA act to limit patent abuses on inhalers, we will likely waste billions of dollars in the coming years.
🧵👇
washingtonpost.com/opinions/2023/…
Unless Congress and the FDA act to limit patent abuses on inhalers, we will likely waste billions of dollars in the coming years.
🧵👇
washingtonpost.com/opinions/2023/…